VRS
NKTR icon

Virginia Retirement Systems’s Nektar Therapeutics NKTR Stock Holding History

Virginia Retirement Systems’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,073
Closed -$289K – 1137
2021
Q3 		$289K Sell
1,073
-27
-2% -$6.49K ﹤0.01% 890
2021
Q2 		$283K Buy
1,100
+253
+30% +$70K ﹤0.01% 932
2021
Q1 		$254K Buy
847
+47
+6% +$14.6K ﹤0.01% 1031
2020
Q4 		$204K Sell
800
-160
-17% -$41.3K ﹤0.01% 1058
2020
Q3 		$239K Sell
960
-473
-33% -$149K ﹤0.01% 991
2020
Q2 		$498K Buy
1,433
+53
+4% +$16.5K 0.01% 800
2020
Q1 		$369K Sell
1,380
-873
-39% -$270K 0.01% 883
2019
Q4 		$730K Buy
+2,253
New +$653K 0.01% 823
2018
Q4 		– Sell
-807
Closed -$738K – 1102
2018
Q3 		$738K Hold
807
– – 0.01% 804
2018
Q2 		$591K Buy
807
+640
+383% +$738K 0.01% 856
2018
Q1 		$266K Buy
+167
New +$215K ﹤0.01% 921

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Virginia Retirement Systems's NKTR Position: Q4 2021 in Review

Virginia Retirement Systems sold out of Nektar Therapeutics (NKTR) in Q4 2021, closing a stake of 1,073 shares — an estimated $289K sold.

Virginia Retirement Systems first reported a position in NKTR in Q1 2018 and held it in 11 quarters. The position peaked at $738K in Q3 2018. 240 funds tracked by Wall St. Rank hold NKTR as of Q4 2021.

  • Virginia Retirement Systems reported no remaining Nektar Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Virginia Retirement Systems sold 1,073 Nektar Therapeutics shares in Q4 2021, an estimated $289K.
  • Virginia Retirement Systems first reported a position in Nektar Therapeutics in Q1 2018 and held it in 11 quarters.
  • Virginia Retirement Systems's Nektar Therapeutics position peaked at $738K in Q3 2018.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2021.

Based on Virginia Retirement Systems's 13F filing for Q4 2021, filed 3 Feb 2022.